Author
Listed:
- Cornelis H. Werkhoven
(University Medical Center Utrecht, Utrecht University)
- Annie Ducher
(Da Volterra)
- Matilda Berkell
(Vaccine & Infectious Disease Institute, University of Antwerp)
- Mohamed Mysara
(Vaccine & Infectious Disease Institute, University of Antwerp
Belgian Nuclear Research Centre, SCK.CEN)
- Christine Lammens
(Vaccine & Infectious Disease Institute, University of Antwerp)
- Julian Torre-Cisneros
(Reina Sofia University Hospital, University of Cordoba (UCO))
- Jesús Rodríguez-Baño
(Hospital Universitario Virgen Macarena
Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS))
- Delia Herghea
(Oncology Institute Prof. Dr. I Chiricuta)
- Oliver A. Cornely
(Faculty of Medicine and University Hospital of Cologne, University of Cologne
University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD)
Partner Site Bonn-Cologne)
- Lena M. Biehl
(Faculty of Medicine and University Hospital of Cologne, University of Cologne
Partner Site Bonn-Cologne)
- Louis Bernard
(Centre hospitalo-universitaire de Tours)
- M. Angeles Dominguez-Luzon
(Universitat de Barcelona)
- Sofia Maraki
(University Hospital of Heraklion)
- Olivier Barraud
(Université Limoges, INSERM U1092, Centre Hospitalier Universitaire de Limoges)
- Maria Nica
(Infectious and Tropical Diseases Hospital “Dr. Victor Babes”)
- Nathalie Jazmati
(Immunology and Hygiene, University of Cologne
Labor Dr. Wisplinghoff)
- Frederique Sablier-Gallis
(Da Volterra)
- Jean Gunzburg
(Da Volterra)
- France Mentré
(Université de Paris, INSERM, IAME)
- Surbhi Malhotra-Kumar
(Vaccine & Infectious Disease Institute, University of Antwerp)
- Marc J. M. Bonten
(University Medical Center Utrecht, Utrecht University
University Medical Center Utrecht, Utrecht University)
- Maria J. G. T. Vehreschild
(Faculty of Medicine and University Hospital of Cologne, University of Cologne
Partner Site Bonn-Cologne
University Hospital Frankfurt, Goethe University Frankfurt)
Abstract
Trial enrichment using gut microbiota derived biomarkers by high-risk individuals can improve the feasibility of randomized controlled trials for prevention of Clostridioides difficile infection (CDI). Here, we report in a prospective observational cohort study the incidence of CDI and assess potential clinical characteristics and biomarkers to predict CDI in 1,007 patients ≥ 50 years receiving newly initiated antibiotic treatment with penicillins plus a beta-lactamase inhibitor, 3rd/4th generation cephalosporins, carbapenems, fluoroquinolones or clindamycin from 34 European hospitals. The estimated 90-day cumulative incidences of a first CDI episode is 1.9% (95% CI 1.1-3.0). Carbapenem treatment (Hazard Ratio (95% CI): 5.3 (1.7-16.6)), toxigenic C. difficile rectal carriage (10.3 (3.2-33.1)), high intestinal abundance of Enterococcus spp. relative to Ruminococcus spp. (5.4 (2.1-18.7)), and low Shannon alpha diversity index as determined by 16 S rRNA gene profiling (9.7 (3.2-29.7)), but not normalized urinary 3-indoxyl sulfate levels, predicts an increased CDI risk.
Suggested Citation
Cornelis H. Werkhoven & Annie Ducher & Matilda Berkell & Mohamed Mysara & Christine Lammens & Julian Torre-Cisneros & Jesús Rodríguez-Baño & Delia Herghea & Oliver A. Cornely & Lena M. Biehl & Louis B, 2021.
"Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics,"
Nature Communications, Nature, vol. 12(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22269-y
DOI: 10.1038/s41467-021-22269-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22269-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.